The Global Vasectomy Market size to reach at a CAGR during the forecast period (2024-2031).
A vasectomy is a surgical procedure that involves the cutting and sealing of the vas deferens, the tubes that carry sperm from the testicles to the urethra. This is a form of permanent birth control for men, as it prevents sperm from mixing with semen during ejaculation, making pregnancy impossible. The procedure is typically done in a clinic and is considered highly effective.
A vasectomy is a popular and permanent contraception method for men, providing a safe and simple way to prevent unwanted pregnancies. It is a relatively quick and minimally invasive procedure, often performed under local anesthesia with minimal recovery time. Many men opt for vasectomy if they are certain they do not want more children.
While reversal is sometimes possible, it is not guaranteed, so a vasectomy should be considered a permanent solution. The procedure is also associated with a low risk of complications, and most men return to their normal activities within a few days. In addition to its effectiveness, vasectomy is seen as a cost-effective and non-hormonal option compared to other forms of contraception.
Download Free Sample PDF: https://www.datamintelligence.com/download-sample/vasectomy-market
Market Growth Drivers:
Innovative technologies for the Vasectomy procedure are expected to drive market growth.
Focused ultrasound is an innovative, non-invasive treatment that shows great potential in enhancing the quality of life for vasectomy patients while reducing healthcare costs. This advanced technology uses concentrated ultrasonic energy beams to target specific areas within the body, leaving surrounding healthy tissue unharmed. The ultrasound precisely ablates (destroys) tissue by applying heat where the beams converge, making vasectomy procedures less invasive, and in some cases, potentially no physical incision is needed.
What’s more, focused ultrasound allows for repeatable treatments if necessary, and it does not introduce the risks associated with chemical agents. This approach is expected to drive the growth of the market in the forecast period, offering better outcomes and more efficient procedures for patients.
Market growth may be impacted by the side effects linked to vasectomy surgical procedures. For example, signs of infection, such as fever, chills, redness, swelling, severe pain, bleeding or discharge at the incision site, difficulty urinating, and uncontrolled pain, could deter some individuals from opting for the procedure. These complications may affect the overall adoption of vasectomy as a preferred method.
Industry Analysis: Porter’s Five Forces –
Supply Chain Analysis: –
Market Segments:
- By Type: Conventional Vasectomy, No-Scalpel Vasectomy, Minimally Invasive Vasectomy
- By Drugs: Anesthetics, Antibiotics, PainkillersWarfarin (Coumadin, Jantoven, others), Heparin, Ibuprofen (Advil, Motrin IB, others), Others
- By Patient: Human, Animal
- By End user: Hospitals, Ambulatory Surgical Center, Others
- By Distribution Channel: Hospital Pharmacy, Retail Pharmacy, Online Pharmacy, Others
- By Region: North America, Latin America, Europe, Asia Pacific, Middle East and Africa
Top Key Players:
- Bristol-Myers Squibb Company
- Teva Pharmaceuticals USA, Inc.
- Upsher-Smith Laboratories, LLC
- Pfizer Inc.
- Smithfield BioScience
- Opocrin S.p.A.
- Bioiberica S.A.U.
- GlaxoSmithKline plc.
- Johnson & Johnson Consumer Inc.
- Fresenius SE & Co. KGaA
Customize Your Scope: https://www.datamintelligence.com/customize/vasectomy-market
Regional Growth
North America region holds the largest market share in the global vasectomy market
In 2021, North America led the market, accounting for the highest revenue share. Several factors are expected to drive further market growth in the region, including the increasing popularity of vasectomy, the growing geriatric population, well-established healthcare infrastructure, advancements in diagnostics, and a rise in clinical trials.
For example, according to the American Urological Association, conception occurs in about 1 in 2,000 couples where one partner has had a vasectomy. In the U.S., approximately 50 million men have undergone the procedure, which accounts for 5% of all reproductive-age married men, with over 500,000 men choosing vasectomy annually. This surge in demand for surgical procedures highlights the growing interest in vasectomy, positioning North America to maintain its dominant market share in the forecast period.
